On November 8, the Department of Labor (DOL) issued an opinion letter addressing an interesting question under the Family and ...
Microbot Medical said Liberty eliminates the need for large and expensive capital equipment and streamlines customers' access ...
Acrivon Therapeutics develops innovative cancer therapies with companion diagnostics. Read why ACRV stock has upside ...
New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...
The data include an interim look at the dose-escalation portion of a phase 2 trial assessing the adenosine A2A receptor ...
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...
Virginia G. Kaklamani, MD, DSc, discusses how effective elacestrant (Orserdu) is in CDK4/6 inhibitor-naive estrogen ...
Keros Therapeutics, Inc.'s stock plummets 75% due to safety concerns in Phase 2 trial, but partnership with Takeda may offer ...
ACRO’s RBQM Working Group has announced the publication of its latest RBM/RBQM paper, Risk-Based Quality Management: A Case for Centralized Mon ...
Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis ...
The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...
Hosted on MSN5hOpinion
A New Fad: Microdosing Ozempic
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...